SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BRADLEY PHARMACEUTICALS (BPRXA)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Brad Glassma3/25/1996 1:10:00 PM
   of 41
 
It is not in their economies of scope or economies of scale. It 's not
that they can't it's that when compared to other investments the
returns of allocating resources to little products is not effective.
Two examples of companies that have done exceedingly well utilizing BRADLEY'S
strategy is DURA (DURA) Pharm. and JONES MEDICAL (JMED). Another
firm that was successful in this strategy (although it has fallen on
hard times) is ROBERTS PHARM (RPCX).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News